EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Explanted malignancies after lung transplantation: the University of Michigan experience

Jarred R Mondoñedo iD, Tao Huang, Jules Lin, Elliot Wakeam

Interactive CardioVascular and Thoracic Surgery · 09.07.2022 · 35 (2)

DOI: 10.1093/icvts/ivac203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Interactive CardioVascular and Thoracic Surgery, online erschienen am 25.07.2022. Verfasst von Jarred R Mondoñedo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Carcinoid Tumor, Lung Neoplasms, Lung Transplantation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Michigan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of patients with an explanted malignancy after lung transplantation is not well understood. We reviewed our institutional experience and outcomes at a single academic medical centre between December 1997 and April 2021 for patients with malignancies of all histologic types identified on explant pathology. Primary lung cancers were reclassified using the 8th Edition TNM staging and the 2021 World Health Organization histologic classification of lung cancers. Of the 733 patients undergoing lung transplantation, 15 (2.05%) were found to have malignancy on the explanted lungs, including 6 (0.82%) primary lung cancers. Four patients were found to have early-stage lung cancers, while 2 patients had advanced-stage IV disease. Survival ranged from 0 to 109 months for the entire cohort with median 23.2 [49.9] months in those with primary lung cancers. There were 2 recurrences following explanted stage I (15 months) and stage IV (53 months) diseases. Other explant pathologies included carcinoid tumourlets in 6 patients, lymphoma in 2 and metastatic leiomyosarcoma in 1. In conclusion, explanted lung malignancies are an infrequent but significant finding on explant pathology. Further data are needed to better characterize and stratify this patient cohort.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoid TumorLung NeoplasmsLung TransplantationHumansLungNeoplasm StagingPrognosisRetrospective Studies

Stichwörter der Autor:innen

Lung cancerLung transplantPatient survival

Autor:innen und Institutionen

  • Section of Thoracic Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pathology, University of Michigan, Ann Arbor, MI, USA.

ORCID-Profile: Jarred R Mondoñedo

Förderung

  • University of Michigan

Zitieren

APA

Mondoñedo, J. R., Huang, T., Lin, J., & Wakeam, E. (2022). Explanted malignancies after lung transplantation: the University of Michigan experience. Interactive CardioVascular and Thoracic Surgery, 35(2). https://doi.org/10.1093/icvts/ivac203

Vancouver

Mondoñedo JR, Huang T, Lin J, Wakeam E. Explanted malignancies after lung transplantation: the University of Michigan experience. Interactive CardioVascular and Thoracic Surgery. 2022;35(2). doi:10.1093/icvts/ivac203

BibTeX
@article{Mondoedo2022,
  author = {Mondoñedo, Jarred R and Huang, Tao and Lin, Jules and Wakeam, Elliot},
  title = {Explanted malignancies after lung transplantation: the University of Michigan experience},
  journal = {Interactive CardioVascular and Thoracic Surgery},
  year = {2022},
  volume = {35},
  number = {2},
  doi = {10.1093/icvts/ivac203}
}
Kostenlos starten →